Drug intelligence / Profile preview

cefotetan

Development stage
Approved
Lead developer
Astellas Pharma
Modality
Small Molecules
Administration
Intravenous, Intramuscular
01

Overview

Cefotetan is a semisynthetic, broad-spectrum cephamycin antibiotic of the second-generation cephalosporin class. It is administered intravenously or intramuscularly and is highly resistant to a broad spectrum of beta-lactamases, making it effective against many aerobic and anaerobic gram-positive and gram-negative bacteria. Its primary mechanism of action involves inhibiting bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), which are essential for peptidoglycan cross-linking in the bacterial cell wall, ultimately leading to cell lysis and death. Cefotetan is used for the prophylaxis and treatment of various bacterial infections, including those affecting the urinary tract, bones and joints, lower respiratory tract, skin, blood, stomach area (intra-abdominal), and female reproductive organs[1][2][3][4][5][6][7]. It is commonly used perioperatively to prevent surgical site infections.

Brand names
Cefotan
Other names
cefotetan disodium
02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on cefotetan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cefotetan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call